Histotype
Myeloma
| Parameter | Information |
|---|---|
| Strain | C.B-17 SCID |
| Implant Type | Intravenous |
| Time to Staging | 7 days |
| Time to Evaluation Size (days) | N/A |
| Td | 2.8 days |
The above parameters are from one study. For further information on this cell line and other parameters, including different strains, vendors, implant type and location and/or standards of care, please contact us.
Human
2654